Carlos Iribarren1, Alfred D Round2, Meng Lu2, Peter M Okin3, Edward J McNulty4. 1. Division of Research, Kaiser Permanente, Oakland, CA cgi@dor.kaiser.org. 2. Division of Research, Kaiser Permanente, Oakland, CA. 3. Division of Cardiology, Department of Medicine, Weill Cornell Medical College, New York, NY. 4. Cardiology Department, Kaiser Permanente San Francisco Medical Center, San Francisco, CA.
Abstract
BACKGROUND: ECG left ventricular hypertrophy (LVH) is a well-known predictor of cardiovascular disease. However, no prior study has characterized patterns of presence/absence of ECG LVH ("ECG LVH trajectories") across the adult lifespan in both sexes and across ethnicities. We examined: (1) correlates of ECG LVH trajectories; (2) the association of ECG LVH trajectories with incident coronary heart disease, transient ischemic attack, ischemic stroke, hemorrhagic stroke, and heart failure; and (3) reclassification of cardiovascular disease risk using ECG LVH trajectories. METHODS AND RESULTS: We performed a cohort study among 75 412 men and 107 954 women in the Northern California Kaiser Permanente Medical Care Program who had available longitudinal exposures of ECG LVH and covariates, followed for a median of 4.8 (range <1-9.3) years. ECG LVH was measured by Cornell voltage-duration product. Adverse trajectories of ECG LVH (persistent, new development, or variable pattern) were more common among blacks and Native American men and were independently related to incident cardiovascular disease with hazard ratios ranging from 1.2 for ECG LVH variable pattern and transient ischemic attack in women to 2.8 for persistent ECG LVH and heart failure in men. ECG LVH trajectories reclassified 4% and 7% of men and women with intermediate coronary heart disease risk, respectively. CONCLUSIONS: ECG LVH trajectories were significant indicators of coronary heart disease, stroke, and heart failure risk, independently of level and change in cardiovascular disease risk factors, and may have clinical utility.
BACKGROUND: ECG left ventricular hypertrophy (LVH) is a well-known predictor of cardiovascular disease. However, no prior study has characterized patterns of presence/absence of ECG LVH ("ECG LVH trajectories") across the adult lifespan in both sexes and across ethnicities. We examined: (1) correlates of ECG LVH trajectories; (2) the association of ECG LVH trajectories with incident coronary heart disease, transient ischemic attack, ischemic stroke, hemorrhagic stroke, and heart failure; and (3) reclassification of cardiovascular disease risk using ECG LVH trajectories. METHODS AND RESULTS: We performed a cohort study among 75 412 men and 107 954 women in the Northern California Kaiser Permanente Medical Care Program who had available longitudinal exposures of ECG LVH and covariates, followed for a median of 4.8 (range <1-9.3) years. ECG LVH was measured by Cornell voltage-duration product. Adverse trajectories of ECG LVH (persistent, new development, or variable pattern) were more common among blacks and Native American men and were independently related to incident cardiovascular disease with hazard ratios ranging from 1.2 for ECG LVH variable pattern and transient ischemic attack in women to 2.8 for persistent ECG LVH and heart failure in men. ECG LVH trajectories reclassified 4% and 7% of men and women with intermediate coronary heart disease risk, respectively. CONCLUSIONS: ECG LVH trajectories were significant indicators of coronary heart disease, stroke, and heart failure risk, independently of level and change in cardiovascular disease risk factors, and may have clinical utility.
Authors: David C Goff; Donald M Lloyd-Jones; Glen Bennett; Sean Coady; Ralph B D'Agostino; Raymond Gibbons; Philip Greenland; Daniel T Lackland; Daniel Levy; Christopher J O'Donnell; Jennifer G Robinson; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Paul Sorlie; Neil J Stone; Peter W F Wilson; Harmon S Jordan; Lev Nevo; Janusz Wnek; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Lesley H Curtis; David DeMets; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Sidney C Smith; Gordon F Tomaselli Journal: Circulation Date: 2013-11-12 Impact factor: 29.690
Authors: Peter M Okin; Richard B Devereux; Sverker Jern; Sverre E Kjeldsen; Stevo Julius; Markku S Nieminen; Steven Snapinn; Katherine E Harris; Peter Aurup; Jonathan M Edelman; Hans Wedel; Lars H Lindholm; Björn Dahlöf Journal: JAMA Date: 2004-11-17 Impact factor: 56.272
Authors: Ching-Hui Sia; Mayank Dalakoti; Benjamin Y Q Tan; Edward C Y Lee; Xiayan Shen; Kangjie Wang; Joshua S Lee; Shalini Arulanandam; Weien Chow; Tee Joo Yeo; Khung Keong Yeo; Terrance S J Chua; Ru San Tan; Carolyn S P Lam; Daniel T T Chong Journal: Ann Noninvasive Electrocardiol Date: 2019-02-01 Impact factor: 1.468
Authors: Yan Hou; Kathleen A Ryan; Carolyn A Cronin; Elizabeth M Aradine; John W Cole; Seemant Chaturvedi; Marcella A Wozniak; Prachi Mehndiratta; Michael S Phipps; Karen L Yarbrough; Mohammad Yousaf; Steven J Kittner Journal: J Stroke Cerebrovasc Dis Date: 2022-07-04 Impact factor: 2.677
Authors: Stacey E Alexeeff; Kamala Deosaransingh; Noelle S Liao; Stephen K Van Den Eeden; Joel Schwartz; Stephen Sidney Journal: Am J Respir Crit Care Med Date: 2021-07-15 Impact factor: 30.528
Authors: David Stevens; Deirdre A Lane; Stephanie L Harrison; Gregory Y H Lip; Ruwanthi Kolamunnage-Dona Journal: BMC Med Res Methodol Date: 2021-12-18 Impact factor: 4.615
Authors: Andreas D Knudsen; Claus Graff; Jonas Bille Nielsen; Magda Teresa Thomsen; Julie Høgh; Thomas Benfield; Jan Gerstoft; Lars Køber; Klaus F Kofoed; Susanne D Nielsen Journal: Sci Rep Date: 2021-10-21 Impact factor: 4.379
Authors: Fernando Focaccia Povoa; Braulio Luna Filho; Henrique Tria Bianco; Celso Amodeo; Rui Povoa; Maria Teresa Nogueira Bombig; Roberto Dischinger Miranda; Simone Matheus Fischer; Maria Cristina Oliveira Izar; Francisco A H Fonseca Journal: Arq Bras Cardiol Date: 2021-11 Impact factor: 2.000